$CLVT
CLARIVATE PLC

2022 Q1 Form 10-Q Financial Statement

#000176404622000090 Filed on May 09, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $662.2M $428.4M
YoY Change 54.58% 78.06%
Cost Of Revenue $249.2M $147.9M
YoY Change 68.49% 78.84%
Gross Profit $413.0M $280.5M
YoY Change 47.24% 77.64%
Gross Profit Margin 62.37% 65.48%
Selling, General & Admin $193.7M $134.3M
YoY Change 44.23% 0.94%
% of Gross Profit 46.9% 47.88%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $176.4M $131.6M
YoY Change 34.04% 5550.49%
% of Gross Profit 42.71% 46.92%
Operating Expenses $193.7M $462.6M
YoY Change -58.13% 72.05%
Operating Profit $44.90M -$69.50M
YoY Change -164.6% 145.51%
Interest Expense $59.50M $37.40M
YoY Change 59.09% 20.88%
% of Operating Profit 132.52%
Other Income/Expense, Net
YoY Change
Pretax Income $85.80M -$55.70M
YoY Change -254.04% -51.51%
Income Tax $16.30M $300.0K
% Of Pretax Income 19.0%
Net Earnings $69.50M -$56.00M
YoY Change -224.11% -56.8%
Net Earnings / Revenue 10.5% -13.07%
Basic Earnings Per Share $0.07 -$0.09
Diluted Earnings Per Share -$0.06 -$0.17
COMMON SHARES
Basic Shares Outstanding 682.5M shares 602.3M shares
Diluted Shares Outstanding 688.0M shares 612.6M shares

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $500.2M $399.0M
YoY Change 25.36% 29.55%
Cash & Equivalents $500.2M $399.0M
Short-Term Investments
Other Short-Term Assets $76.90M $230.2M
YoY Change -66.6% 941.76%
Inventory
Prepaid Expenses $97.70M $64.39M
Receivables $859.8M $706.9M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.550B $1.414B
YoY Change 9.62% 94.17%
LONG-TERM ASSETS
Property, Plant & Equipment $160.6M $33.57M
YoY Change 378.47% 46.23%
Goodwill $7.803B $6.246B
YoY Change 24.93% 242.63%
Intangibles $10.14B $7.266B
YoY Change 39.52% 218.38%
Long-Term Investments
YoY Change
Other Assets $63.10M $42.50M
YoY Change 48.46% 86.27%
Total Long-Term Assets $18.19B $13.70B
YoY Change 32.8% 220.79%
TOTAL ASSETS
Total Short-Term Assets $1.550B $1.414B
Total Long-Term Assets $18.19B $13.70B
Total Assets $19.74B $15.11B
YoY Change 30.63% 202.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $117.3M $94.55M
YoY Change 24.06% 230.78%
Accrued Expenses $526.7M $532.0M
YoY Change -1.0% 100.75%
Deferred Revenue $1.081B $769.0M
YoY Change 40.52% 62.89%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $30.60M $28.60M
YoY Change 6.99% 126.98%
Total Short-Term Liabilities $1.791B $1.467B
YoY Change 22.05% 88.54%
LONG-TERM LIABILITIES
Long-Term Debt $5.452B $3.453B
YoY Change 57.89% 80.28%
Other Long-Term Liabilities $143.2M $62.14M
YoY Change 130.44% 234.95%
Total Long-Term Liabilities $143.2M $3.515B
YoY Change -95.93% 81.76%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.791B $1.467B
Total Long-Term Liabilities $143.2M $3.515B
Total Liabilities $8.034B $5.718B
YoY Change 40.52% 96.75%
SHAREHOLDERS EQUITY
Retained Earnings -$1.553B -$1.236B
YoY Change 25.63%
Common Stock $11.82B $10.11B
YoY Change 16.87% 233.31%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares 2.489M shares 0.000 shares
Shareholders Equity $11.71B $9.119B
YoY Change
Total Liabilities & Shareholders Equity $19.74B $15.11B
YoY Change 30.63% 202.34%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income $69.50M -$56.00M
YoY Change -224.11% -56.8%
Depreciation, Depletion And Amortization $176.4M $131.6M
YoY Change 34.04% 5550.49%
Cash From Operating Activities $67.40M $174.0M
YoY Change -61.26% 277.39%
INVESTING ACTIVITIES
Capital Expenditures $41.40M $33.00M
YoY Change 25.45% 70.15%
Acquisitions $1.300M -$400.0K
YoY Change -425.0% -100.05%
Other Investing Activities -$1.300M $400.0K
YoY Change -425.0% -100.05%
Cash From Investing Activities -$42.70M -$32.60M
YoY Change 30.98% -96.38%
FINANCING ACTIVITIES
Cash Dividend Paid $18.90M
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$88.80M -$6.600M
YoY Change 1245.45% -100.6%
NET CHANGE
Cash From Operating Activities $67.40M $174.0M
Cash From Investing Activities -$42.70M -$32.60M
Cash From Financing Activities -$88.80M -$6.600M
Net Change In Cash -$71.90M $143.5M
YoY Change -150.1% -38.87%
FREE CASH FLOW
Cash From Operating Activities $67.40M $174.0M
Capital Expenditures $41.40M $33.00M
Free Cash Flow $26.00M $141.0M
YoY Change -81.56% 427.87%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001764046
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
00-0000000
CY2022Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2022Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P3Y
CY2021Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
16900000 USD
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
103500000 USD
CY2022Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P5Y
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-38911
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
CLARIVATE PLC
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
Y9
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
70 St. Mary Axe
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
London
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
EC3A 8BE
CY2022Q1 dei Entity Address Country
EntityAddressCountry
GB
CY2022Q1 dei Country Region
CountryRegion
44
CY2022Q1 dei City Area Code
CityAreaCode
207
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
4334000
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
672549836 shares
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
500200000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
430900000 USD
CY2022Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
15500000 USD
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
156700000 USD
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
859800000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
906400000 USD
CY2022Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
97700000 USD
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
76600000 USD
CY2022Q1 us-gaap Other Assets Current
OtherAssetsCurrent
76900000 USD
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
66600000 USD
CY2022Q1 us-gaap Assets Current
AssetsCurrent
1550100000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1637200000 USD
CY2022Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
80000000.0 USD
CY2021Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
83800000 USD
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
10137900000 USD
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
10392400000 USD
CY2022Q1 us-gaap Goodwill
Goodwill
7803400000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
7904900000 USD
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
63100000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
50800000 USD
CY2022Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
28600000 USD
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
27900000 USD
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
80600000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
86000000.0 USD
CY2022Q1 us-gaap Assets
Assets
19743700000 USD
CY2021Q4 us-gaap Assets
Assets
20183000000 USD
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
117300000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
129200000 USD
CY2022Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
532000000.0 USD
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
679600000 USD
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1080600000 USD
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1030400000 USD
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
30500000 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
32200000 USD
CY2022Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
30600000 USD
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
30600000 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1791000000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1902000000 USD
CY2022Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
5452000000 USD
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
5456300000 USD
CY2022Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
127400000 USD
CY2021Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
227800000 USD
CY2022Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
54700000 USD
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
54200000 USD
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
143200000 USD
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
142700000 USD
CY2022Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
376700000 USD
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
380100000 USD
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
89100000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
94000000.0 USD
CY2022Q1 us-gaap Liabilities
Liabilities
8034100000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
8257100000 USD
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
14375000 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
14375000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
14375000 shares
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
14375000 shares
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
14375000 shares
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
1392600000 USD
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
1392600000 USD
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
681463527 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
683139210 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
678974630 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
683139210 shares
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
11815000000 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
11827900000 USD
CY2022Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
2488897 shares
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
547136 shares
CY2022Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
48700000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
326700000 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1552800000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1604400000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
11709600000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
11925900000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
19743700000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20183000000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
662200000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
428400000 USD
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
249200000 USD
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
147900000 USD
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
193700000 USD
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
134300000 USD
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
176400000 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
131600000 USD
CY2022Q1 us-gaap Restructuring Charges
RestructuringCharges
11700000 USD
CY2021Q1 us-gaap Restructuring Charges
RestructuringCharges
67900000 USD
CY2022Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
13700000 USD
CY2021Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-16200000 USD
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
617300000 USD
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
497900000 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
44900000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-69500000 USD
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-100400000 USD
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-51200000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
145300000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-18300000 USD
CY2022Q1 us-gaap Interest Expense
InterestExpense
59500000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
37400000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
85800000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-55700000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16300000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
300000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
69500000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-56000000.0 USD
CY2022Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
18700000 USD
CY2021Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
0 USD
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
50800000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-56000000.0 USD
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
682539103 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
602272375 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
687994133 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
612598664 shares
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
69500000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-56000000.0 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
11900000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
1300000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-235100000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
18300000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-223200000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
19600000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-153700000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-36400000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
11925900000 USD
CY2022Q1 us-gaap Stockholders Equity Other Shares
StockholdersEquityOtherShares
-500000 shares
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
400000 USD
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
5400000 USD
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
26900000 USD
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
66400000 USD
CY2022Q1 us-gaap Treasury Stock Reissued At Lower Than Repurchase Price
TreasuryStockReissuedAtLowerThanRepurchasePrice
-600000 USD
CY2022Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
18700000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
69500000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-223200000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-223200000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
11709600000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
9034800000 USD
CY2021Q1 clvt Stock Issued During Period Value Private Warrants Exercised
StockIssuedDuringPeriodValuePrivateWarrantsExercised
3600000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5100000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
4500000 USD
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
105500000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10500000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-56000000.0 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
19600000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
9118600000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
69500000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-56000000.0 USD
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
176400000 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
131600000 USD
CY2022Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-1300000 USD
CY2021Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
200000 USD
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
24600000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1200000 USD
CY2022Q1 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
-900000 USD
CY2021Q1 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
38900000 USD
CY2022Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-6700000 USD
CY2021Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1000000.0 USD
CY2022Q1 clvt Mark To Market Loss On Contingent Shares
MarkToMarketLossOnContingentShares
0 USD
CY2021Q1 clvt Mark To Market Loss On Contingent Shares
MarkToMarketLossOnContingentShares
-25100000 USD
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-100400000 USD
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-51200000 USD
CY2022Q1 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-3600000 USD
CY2021Q1 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-2300000 USD
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
19500000 USD
CY2021Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-7300000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-40200000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-44200000 USD
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
20800000 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
7200000 USD
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
18500000 USD
CY2021Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
900000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-10300000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
13700000 USD
CY2022Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-143900000 USD
CY2021Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
29100000 USD
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
63300000 USD
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
66000000.0 USD
CY2022Q1 clvt Increase Decrease Operating Lease Right Of Use Assets
IncreaseDecreaseOperatingLeaseRightOfUseAssets
-4600000 USD
CY2021Q1 clvt Increase Decrease Operating Lease Right Of Use Assets
IncreaseDecreaseOperatingLeaseRightOfUseAssets
-7500000 USD
CY2022Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-5100000 USD
CY2021Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-25700000 USD
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-800000 USD
CY2021Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-900000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
67400000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
174000000.0 USD
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
41400000 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
33000000.0 USD
CY2022Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1300000 USD
CY2021Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-400000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-42700000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-32600000 USD
CY2022Q1 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
7200000 USD
CY2021Q1 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
7200000 USD
CY2022Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
2100000 USD
CY2021Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
CY2022Q1 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
55100000 USD
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
18900000 USD
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
400000 USD
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5100000 USD
CY2022Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
500000 USD
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
5400000 USD
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4500000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-88800000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6600000 USD
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-7800000 USD
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8700000 USD
CY2022Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
69300000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
141300000 USD
CY2022Q1 clvt Restricted Cash Period Increase Decrease
RestrictedCashPeriodIncreaseDecrease
-141200000 USD
CY2021Q1 clvt Restricted Cash Period Increase Decrease
RestrictedCashPeriodIncreaseDecrease
2200000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-71900000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
143500000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
430900000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
257700000 USD
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
156700000 USD
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
14700000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
587600000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
272400000 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
500200000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
399000000.0 USD
CY2022Q1 us-gaap Restricted Cash
RestrictedCash
15500000 USD
CY2021Q1 us-gaap Restricted Cash
RestrictedCash
16900000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
515700000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
415900000 USD
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
27800000 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
27300000 USD
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
3600000 USD
CY2021Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
2600000 USD
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
7700000 USD
CY2021Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
6100000 USD
CY2022Q1 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
33300000 USD
CY2022Q1 clvt Treasury Stock Value Acquired Cost Method Settled In Subsequent Period
TreasuryStockValueAcquiredCostMethodSettledInSubsequentPeriod
11300000 USD
CY2022Q1 us-gaap Preferred Stock Amount Of Preferred Dividends In Arrears
PreferredStockAmountOfPreferredDividendsInArrears
6400000 USD
CY2022Q1 clvt Total Non Cash Financing Activities
TotalNonCashFinancingActivities
-15600000 USD
CY2021Q1 clvt Total Non Cash Financing Activities
TotalNonCashFinancingActivities
105500000 USD
CY2022Q1 us-gaap Nature Of Operations
NatureOfOperations
Background and Nature of Operations <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clarivate Plc (“Clarivate,” “us,” “we,” “our,” or the “Company”), is a public limited company organized under the laws of Jersey, Channel Islands, pursuant to the definitive agreement entered into on May 13, 2019 to effect a merger between Camelot Holdings (Jersey) Limited ("Jersey") and Churchill Capital Corp, a Delaware corporation, ("Churchill") (the “2019 Transaction”). The Company is a provider of proprietary and comprehensive content, analytics, professional services and workflow solutions that enable users across government and academic institutions, life science companies and research and development (“R&amp;D”) intensive corporations to discover, protect and commercialize their innovations. Clarivate has two reportable segments: Science and Intellectual Property ("IP"). See Note 18 - Segment Information, for additional information on the Company's reportable segments. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks and Uncertainties</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the World Health Organization characterized COVID-19 as a pandemic. The rapid spread of COVID-19 and issues relating to the resurgence of COVID-19 and/or new strains of COVID-19 along with continuously evolving responses to combat it have had an increasingly negative impact on the global economy. This has had, and may continue to have, an adverse impact to our operational and financial performance as well as the businesses of our customers and partners, including their spending priorities. It is difficult to predict the full extent of the potential effects and impact on our operations, business, and financial performance, however, we continue to conduct business with substantial modifications and precautionary measures to our daily operations. Modifications include less employee travel as well as a virtual shift related to work location, and sales and marketing events. Given the uncertainty around the severity and duration of the COVID-19 pandemic, the Company cannot reasonably estimate the full impact on our business, financial condition and results of operations at this time, which may be material.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the conflict in Ukraine continues to evolve, we are closely monitoring the current and potential impact on our business, our people, and our clients. Given the levying of sanctions, regional instability, geopolitical shifts, and other potential adverse effects on macroeconomics conditions, security conditions, currency exchange, and financial markets, the short and long-term implications of Russia’s invasion of Ukraine are not possible to predict. We do not expect any direct impacts to our business to be material, but we are not currently able to predict any indirect impacts on the global economy and how those could negatively affect our business in the future. We continue to monitor any evolving impacts of this conflict and its effects on the global economy and geopolitical landscape.</span></div>
CY2022Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2021Q4 us-gaap Share Price
SharePrice
23.34
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
10137900000 USD
CY2021Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
11841800000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1449400000 USD
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
10392400000 USD
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
165800000 USD
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
128300000 USD
CY2021Q1 us-gaap Sublease Income
SubleaseIncome
800000 USD
CY2022Q1 us-gaap Sublease Income
SubleaseIncome
800000 USD
CY2022Q1 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
31000000.0 USD
CY2021Q4 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
30500000 USD
CY2022Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
130400000 USD
CY2021Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
124600000 USD
CY2022Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
50400000 USD
CY2021Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
40800000 USD
CY2022Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
80000000.0 USD
CY2021Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
83800000 USD
CY2022Q1 us-gaap Depreciation
Depreciation
10600000 USD
CY2021Q1 us-gaap Depreciation
Depreciation
3300000 USD
CY2021Q1 us-gaap Impairment Of Leasehold
ImpairmentOfLeasehold
1000000.0 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
11580300000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1603700000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
9976600000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
11680500000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1449400000 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
10231100000 USD
CY2022Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
11741600000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1603700000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
7904900000 USD
CY2022Q1 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-2400000 USD
CY2022Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
99100000 USD
CY2022Q1 us-gaap Goodwill
Goodwill
7803400000 USD
CY2022Q1 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
0 USD
CY2021Q1 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
41000000.0 USD
CY2022Q1 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
-200000 USD
CY2021Q1 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
-3100000 USD
CY2022Q1 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
9800000 USD
CY2021Q4 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
152400000 USD
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
98300000 USD
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
150600000 USD
CY2022Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
35800000 USD
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
39400000 USD
CY2022Q1 us-gaap Litigation Reserve Current
LitigationReserveCurrent
76700000 USD
CY2021Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
79000000.0 USD
CY2022Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
35800000 USD
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
28500000 USD
CY2022Q1 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
69500000 USD
CY2021Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
71300000 USD
CY2022Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
206100000 USD
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
158400000 USD
CY2022Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
532000000.0 USD
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
679600000 USD
CY2021Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
30800000 USD
CY2022Q1 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
5559600000 USD
CY2022Q1 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
60400000 USD
CY2021Q4 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
60500000 USD
CY2022Q1 clvt Treasury Stock Value Acquired Cost Method Settled In Subsequent Period
TreasuryStockValueAcquiredCostMethodSettledInSubsequentPeriod
11300000 USD
CY2022Q1 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.03800
CY2022Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
30300000 USD
CY2021Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.03800
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
5567200000 USD
CY2022Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
45000000.0 USD
CY2021Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
47100000 USD
CY2022Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
32000000.0 USD
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
33200000 USD
CY2022Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
30600000 USD
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
30600000 USD
CY2022Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
5452000000 USD
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
5456300000 USD
CY2021Q4 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
175000000.0 USD
CY2022Q1 clvt Revenue From Contract With Customer Excluding Assessed Tax Including Deferred Revenues Adjustment
RevenueFromContractWithCustomerExcludingAssessedTaxIncludingDeferredRevenuesAdjustment
662000000.0 USD
CY2021Q1 clvt Revenue From Contract With Customer Excluding Assessed Tax Including Deferred Revenues Adjustment
RevenueFromContractWithCustomerExcludingAssessedTaxIncludingDeferredRevenuesAdjustment
431400000 USD
CY2022Q1 clvt Contractwith Customer Liability Adjustments
ContractwithCustomerLiabilityAdjustments
-200000 USD
CY2021Q1 clvt Contractwith Customer Liability Adjustments
ContractwithCustomerLiabilityAdjustments
3000000.0 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
662200000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
428400000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
906400000 USD
CY2022Q1 us-gaap Common Stock Voting Rights
CommonStockVotingRights
one
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1030400000 USD
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
54200000 USD
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
859800000 USD
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1080600000 USD
CY2022Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
54700000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
46600000 USD
CY2022Q1 clvt Increase Decrease In Contract With Customer Current Liability
IncreaseDecreaseInContractWithCustomerCurrentLiability
-50200000 USD
CY2022Q1 clvt Increase Decrease In Contract With Customer Non Current Liability
IncreaseDecreaseInContractWithCustomerNonCurrentLiability
-500000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
737700000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
707300000 USD
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
41400000 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
706900000 USD
CY2021Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
769000000.0 USD
CY2021Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
45400000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
30800000 USD
CY2021Q1 clvt Increase Decrease In Contract With Customer Current Liability
IncreaseDecreaseInContractWithCustomerCurrentLiability
-61700000 USD
CY2021Q4 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
30.99
CY2021Q1 clvt Increase Decrease In Contract With Customer Non Current Liability
IncreaseDecreaseInContractWithCustomerNonCurrentLiability
-4000000.0 USD
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
354000000.0 USD
CY2021Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
231300000 USD
CY2022Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
124600000 USD
CY2022Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.571
CY2022Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2022Q1 clvt Revenue Remaining Performance Obligation Greater Than One Year Percentage
RevenueRemainingPerformanceObligationGreaterThanOneYearPercentage
0.429
CY2022Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.241
CY2022Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.116
CY2022Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.072
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
681500000 shares
CY2021Q2 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
100.00
CY2021Q2 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
100.00
CY2022Q1 us-gaap Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
41700 shares
CY2022Q1 clvt Treasury Stock Reissued Average Cost Per Share
TreasuryStockReissuedAverageCostPerShare
15.01
CY2021Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
250000000.0 USD
CY2022Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
1000000000 USD
CY2022Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
4100000 shares
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
66400000 USD
CY2022Q1 clvt Treasury Stock Value Acquired Cost Method Settled In Subsequent Period
TreasuryStockValueAcquiredCostMethodSettledInSubsequentPeriod
11300000 USD
CY2022Q1 us-gaap Treasury Stock Shares Retired
TreasuryStockSharesRetired
2100000 shares
CY2022Q1 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
33300000 USD
CY2022Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
933600000 USD
CY2022Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
4100000 shares
CY2022Q1 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
16.16
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
66400000 USD
CY2022Q1 us-gaap Treasury Stock Shares Retired
TreasuryStockSharesRetired
2100000 shares
CY2022Q1 clvt Treasury Stock Retired Average Cost Per Share
TreasuryStockRetiredAverageCostPerShare
15.71
CY2022Q1 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
33300000 USD
CY2022Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
26600000 USD
CY2021Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
39000000.0 USD
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
0 shares
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16300000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
85800000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
300000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-55700000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
69500000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-56000000.0 USD
CY2022Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
18700000 USD
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
50800000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-56000000.0 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
682500000 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
602300000 shares
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
50800000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-56000000.0 USD
CY2022Q1 us-gaap Dilutive Securities
DilutiveSecurities
-94900000 USD
CY2021Q1 us-gaap Dilutive Securities
DilutiveSecurities
-51200000 USD
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-44100000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-107200000 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
682500000 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
602300000 shares
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
5500000 shares
CY2021Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
10300000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
688000000.0 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
612600000 shares
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
20400000 USD
CY2021Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-16000000.0 USD
CY2022Q1 us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
6700000 USD
CY2021Q1 us-gaap Other Nonrecurring Income Expense
OtherNonrecurringIncomeExpense
200000 USD
CY2022Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
13700000 USD
CY2021Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-16200000 USD
CY2021Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-16200000 USD
CY2022Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
662200000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
428400000 USD
CY2022Q1 clvt Adjusted Ebitda
AdjustedEBITDA
262300000 USD
CY2021Q1 clvt Adjusted Ebitda
AdjustedEBITDA
164800000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16300000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
300000 USD
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
176400000 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
131600000 USD
CY2022Q1 us-gaap Interest Expense
InterestExpense
59500000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
37400000 USD
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-100400000 USD
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-51200000 USD
CY2022Q1 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
60400000 USD
CY2022Q1 clvt Deferred Revenues Adjustment
DeferredRevenuesAdjustment
-200000 USD
CY2021Q1 clvt Deferred Revenues Adjustment
DeferredRevenuesAdjustment
3000000.0 USD
CY2022Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
6700000 USD
CY2021Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
-22900000 USD
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
37000000.0 USD
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
39000000.0 USD
CY2022Q1 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
11700000 USD
CY2021Q1 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
67900000 USD
CY2022Q1 clvt Other Reconciling Items Ebitda To Net Income Loss Attributable To Parent
OtherReconcilingItemsEBITDAToNetIncomeLossAttributableToParent
-14200000 USD
CY2021Q1 clvt Other Reconciling Items Ebitda To Net Income Loss Attributable To Parent
OtherReconcilingItemsEBITDAToNetIncomeLossAttributableToParent
15700000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
69500000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-56000000.0 USD
CY2022Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
18700000 USD
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
50800000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-56000000.0 USD
CY2021Q4 us-gaap Restructuring Reserve
RestructuringReserve
35400000 USD
CY2022Q1 us-gaap Restructuring Charges
RestructuringCharges
11700000 USD
CY2022Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
23800000 USD
CY2022Q1 us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
500000 USD
CY2022Q1 us-gaap Restructuring Reserve
RestructuringReserve
23800000 USD
CY2020Q4 us-gaap Restructuring Reserve
RestructuringReserve
30200000 USD
CY2021Q1 us-gaap Restructuring Charges
RestructuringCharges
67900000 USD
CY2021Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
17000000.0 USD
CY2021Q1 us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
-42300000 USD
CY2021Q1 us-gaap Restructuring Reserve
RestructuringReserve
38800000 USD
CY2022Q1 us-gaap Restructuring Charges
RestructuringCharges
11700000 USD
CY2021Q1 us-gaap Restructuring Charges
RestructuringCharges
67900000 USD
CY2022Q1 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
0.0 USD
CY2021Q1 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
41000000.0 USD
CY2022Q1 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
-200000 USD
CY2021Q1 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
-3100000 USD
CY2022Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
4100000 shares
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
66400000 USD
CY2022Q1 clvt Treasury Stock Value Acquired Cost Method Settled In Subsequent Period
TreasuryStockValueAcquiredCostMethodSettledInSubsequentPeriod
11300000 USD
CY2022Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
1000000000 USD

Files In Submission

Name View Source Status
0001764046-22-000090-index-headers.html Edgar Link pending
0001764046-22-000090-index.html Edgar Link pending
0001764046-22-000090.txt Edgar Link pending
0001764046-22-000090-xbrl.zip Edgar Link pending
clvt-20220331.htm Edgar Link pending
clvt-20220331.xsd Edgar Link pending
clvt-20220331_cal.xml Edgar Link unprocessable
clvt-20220331_def.xml Edgar Link unprocessable
clvt-20220331_htm.xml Edgar Link completed
clvt-20220331_lab.xml Edgar Link unprocessable
clvt-20220331_pre.xml Edgar Link unprocessable
exhibit102-offerletter.htm Edgar Link pending
exhibit103-settlementagree.htm Edgar Link pending
exhibit31-q12022.htm Edgar Link pending
exhibit32-q12022.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
imagea.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending